Plants exhibiting favorable impacts on cognitive impairments, coupled with robust acetylcholinesterase inhibitory, anti-inflammatory, and antioxidant properties, hold promise for clinical consideration in AD therapy (Penido et al. 2017). The gene discussed is ACHE; the disease is Alzheimer disease.